What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Surgery
His primary areas of investigation include Internal medicine, Pathology, Pancreatic cancer, Pancreas and Cancer research.
His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology, Endocrinology, Surgery and Oncology.
The Pathology study combines topics in areas such as Carcinogenesis, Ductal carcinoma and Pancreatic ductal adenocarcinoma.
Within one scientific family, Masao Tanaka focuses on topics pertaining to microRNA under Pancreatic cancer, and may sometimes address concerns connected to Surgical oncology.
His Pancreas study incorporates themes from Malignancy and Adenoma.
His Cancer research research integrates issues from Cancer, Colorectal cancer, Cell growth and Hepatocyte growth factor.
His most cited work include:
- International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. (1642 citations)
- International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas (1629 citations)
- Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas. (514 citations)
What are the main themes of his work throughout his whole career to date?
Masao Tanaka mainly focuses on Internal medicine, Surgery, Gastroenterology, Pathology and Pancreatic cancer.
His studies deal with areas such as Endocrinology and Oncology as well as Internal medicine.
His General surgery research extends to Surgery, which is thematically connected.
Gastroenterology is closely attributed to Pancreatic juice in his research.
Pathology is closely attributed to Metastasis in his study.
His Pancreatic cancer research includes themes of Cancer cell, Gemcitabine and Cancer research.
He most often published in these fields:
- Internal medicine (37.87%)
- Surgery (20.71%)
- Gastroenterology (19.95%)
What were the highlights of his more recent work (between 2012-2021)?
- Internal medicine (37.87%)
- Pathology (19.02%)
- Pancreatic cancer (16.40%)
In recent papers he was focusing on the following fields of study:
Masao Tanaka spends much of his time researching Internal medicine, Pathology, Pancreatic cancer, Surgery and Pancreas.
His studies in Internal medicine integrate themes in fields like Gastroenterology and Oncology.
His Pathology research is multidisciplinary, relying on both Cancer and Metastasis.
Masao Tanaka has included themes like Cancer cell, Gemcitabine and Cancer research in his Pancreatic cancer study.
His work deals with themes such as Oncogene and Hepatic stellate cell, which intersect with Cancer research.
The Pancreas study which covers Carcinoma that intersects with Adenocarcinoma.
Between 2012 and 2021, his most popular works were:
- Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas. (514 citations)
- Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST Study (399 citations)
- Epidemiological trends of pancreatic and gastrointestinal neuroendocrine tumors in Japan: a nationwide survey analysis (174 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Surgery
His scientific interests lie mostly in Internal medicine, Pathology, Pancreas, Pancreatic cancer and Surgery.
His research integrates issues of Gastroenterology and Oncology in his study of Internal medicine.
Masao Tanaka interconnects Tumor progression, Metastasis, Pancreatic ductal adenocarcinoma and Branch Duct in the investigation of issues within Pathology.
In his work, Adenocarcinoma is strongly intertwined with Carcinoma, which is a subfield of Pancreas.
His Pancreatic cancer research is multidisciplinary, incorporating perspectives in Cancer cell and Cancer research.
His research in Surgery tackles topics such as Guideline which are related to areas like Resection.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
